ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $25,643,000 | +200.2% | 275,905 | +92.3% | 0.01% | +200.0% |
Q3 2021 | $8,542,000 | -7.5% | 143,444 | +5.9% | 0.00% | -25.0% |
Q2 2021 | $9,236,000 | -86.8% | 135,427 | -86.6% | 0.00% | -87.1% |
Q1 2021 | $70,021,000 | -5.9% | 1,009,095 | +4.2% | 0.03% | -11.4% |
Q4 2020 | $74,420,000 | -0.9% | 968,636 | -3.5% | 0.04% | -12.5% |
Q3 2020 | $75,084,000 | +10.3% | 1,003,937 | -7.1% | 0.04% | 0.0% |
Q2 2020 | $68,063,000 | +31.4% | 1,081,229 | -12.3% | 0.04% | +8.1% |
Q1 2020 | $51,791,000 | +3.6% | 1,233,128 | +12.0% | 0.04% | +32.1% |
Q4 2019 | $49,987,000 | +3.9% | 1,100,558 | +4.7% | 0.03% | -6.7% |
Q3 2019 | $48,099,000 | -22.2% | 1,050,878 | -0.3% | 0.03% | -21.1% |
Q2 2019 | $61,788,000 | +1748.8% | 1,053,855 | +1313.5% | 0.04% | +1800.0% |
Q1 2019 | $3,342,000 | +16.0% | 74,556 | +0.8% | 0.00% | 0.0% |
Q4 2018 | $2,881,000 | -15.3% | 73,956 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $3,403,000 | +5.6% | 73,956 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $3,224,000 | -25.5% | 73,956 | -32.5% | 0.00% | -33.3% |
Q1 2018 | $4,327,000 | +163.5% | 109,556 | +126.6% | 0.00% | +200.0% |
Q4 2017 | $1,642,000 | -3.4% | 48,344 | -27.5% | 0.00% | 0.0% |
Q3 2017 | $1,700,000 | +164.0% | 66,655 | +74.5% | 0.00% | – |
Q2 2017 | $644,000 | – | 38,194 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |